Advances in Optometric Care

Some eye care specialists may believe they do not have time have time to deal with ocular surface disease — that tackling dry eye disease is too time-consuming, complicated and confusing, potentially making them inefficient with patients.

Undesirable subjective optical patterns known as dysphotopsias are one of the most common complaints following cataract surgery.

With a new pharmaceutical treatment option, my conversations with presbyopic patients have gotten a lot more exciting.

A pharmaceutical approach to presbyopia has clear advantages, will likely be used in combination with other approaches and may serve to drive surgical procedures.

Visual outcomes after cataract surgery depend on accurate planning.

Most patients know about cataracts, but they might not fully understand what they are.

Despite stalls in development due to COVID-19, eye care providers can look forward to new treatments for ocular surface disease. As our understanding of the disease and its underlying mechanisms broadens, so does the industry's response.

Our practice was shuttered at the beginning of the COVID-19 pandemic to all but emergent patients.

This third installment of the current state of LASIK looks at more data and thoughts about the future.

This overview takes a look at the “state of the union” as it relates to LASIK as we know it in this year of vision, 2020. Here is part two, focusing on FDA approval, current iterations and data.